Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

5α-Reductase inhibitors can negatively impact sexual function.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

5-ARI therapy may help prevent prostate cancer progression.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Finasteride, a medication, is being re-evaluated for its effects and uses.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Compound 4 is a promising treatment for hair loss with low toxicity.

5-Alpha-Reductase Inhibitors can cause negative side effects.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.